Food News and Research

RSS

EquityNet Research begins independent coverage on Huifeng Bio-Pharmaceutical Technology

Huifeng Bio-Pharmaceutical Technology, Inc., a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today reported that after preliminary due diligence, including review of the company's market potential and development opportunities, EquityNet Research is initiating coverage of the company as an independent analyst.

22 Dec 2009

Schering and MSP Singapore sue Mylan over generic Vytorin ANDA

Mylan Inc. today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Schering Corporation and MSP Singapore Company in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg. This product is the generic version of Vytorin® Tablets, a cholesterol treatment.

22 Dec 2009

Food safety advocate provides pros and cons of drinking raw milk

Unpasteurized milk — often referred to as raw milk — is at the center of a rally and court appearance today in Viroqua, Wisconsin. The controversial product can contain bacteria, like E. coli, Salmonella and Campylobacter, which can severely sicken those who consume it — bacteria removed by the pasteurization process.

22 Dec 2009

Researchers to discover how to combat the negative aspects of fungi

Mold and mildew may be doomed. Researchers are closer to understanding how these and other fungi grow. "Fungi have a big impact on our dinner plate," said Dr. Brian Shaw, Texas AgriLife Research plant pathologist.

22 Dec 2009

A properly managed metabolic detoxification program can benefit

“Detox” programs have been in the spotlight recently, with a bevy of Hollywood celebrities citing their “detox” programs as the secret to looking great on the red carpet. But, what exactly is detoxification? Is it merely the latest health and beauty fad, or is it a true health therapy? And can anyone besides the Hollywood elite benefit from it?

22 Dec 2009

Projects In Knowledge provides support for local, national, and global organizations

The deep-rooted tradition of charitable giving at Projects In Knowledge (www.projectsinknowledge.com) is kicking into a higher gear during the 2009 holiday season.

22 Dec 2009

ICBS targets U.S.regulatory agencies to sell its TOGS 9000 bio-photonic incubation & detection systems

ICBS Ltd., announced today that it will be targeting U.S. state and municipal regulatory bodies for the sale of the TOGS(TM) 9000 bio-photonic incubation & detection systems.

22 Dec 2009

Study results of CSL’s pandemic H1N1 2009 vaccine published in JAMA

CSL Limited, Australia’s leading biopharmaceutical company, announced the Journal of the American Medical Association (JAMA) has published data from a clinical trial conducted in Australia to study CSL’s pandemic H1N1 2009 ‘swine’ flu vaccine.

22 Dec 2009

Health experts offer recommendation to improve school meal programs

More fruits, vegetables, and whole grains, less sodium and a limit on calories served per meal—those are just some of the recommendations a committee of experts has made on how to improve the nation’s school lunch and breakfast menus.

22 Dec 2009

AADA lauds indoor tanning tax in the health system reform legislation

The American Academy of Dermatology Association (AADA) applauds the decision of the U.S. Senate to substitute a 10 percent federal excise tax on indoor tanning services for the proposed tax on cosmetic procedures in the Senate's health system reform legislation (H.R. 3590, the Patient Protection and Affordability Act of 2009). The indoor tanning tax, as proposed to Senate leadership by the AADA, furthers its goal of promoting wellness and prevention, and removes the harmful unintended consequences associated with a tax on cosmetic surgery procedures.

22 Dec 2009

Cell Therapeutics supports Code on Interactions with Healthcare Professionals

Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.

22 Dec 2009

ZEGERID OTC approval triggers $20M milestone payment to Santarus

Santarus, Inc., a specialty biopharmaceutical company, today announced that it has received the $20 million milestone payment previously announced on December 1, 2009 relating to the approval of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its over-the-counter (OTC) licensing agreement with Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc. Schering-Plough and Merck merged on November 3, 2009.

22 Dec 2009

Charlie DuBois named Dynamic Chiropractic’s 2009 Person of the Year

Charlie DuBois, president of whole food supplement manufacturer Standard Process, has been named Dynamic Chiropractic’s 2009 Person of the Year. Featured in the December 16, 2009 edition of Dynamic Chiropractic magazine, DuBois was selected because of the commitment and support that he has shown the chiropractic profession.

22 Dec 2009

DSM BioSolutions to manufacture Mayoly Spindler's 'MS1819' lipase biotherapeutic

DSM BioSolutions today announced that it has entered into an agreement with Laboratoires Mayoly Spindler, Chatou Cedex, France, for the manufacture of "MS1819" lipase.

22 Dec 2009

Urigen Pharmaceuticals and Oceana Therapeutics jointly prepare for meeting with FDA on URG101

Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that the Company and Oceana Therapeutics have agreed to jointly prepare for a meeting with the U.S. Food & Drug Administration regarding the continued development of URG101.

22 Dec 2009

MAA for naproxcinod submitted to EMEA through centralized procedure

NicOx S.A. today announced that a Marketing Authorization Application (MAA) for naproxcinod has been submitted to the European Medicines Agency (EMEA) through the centralized procedure, seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA).

22 Dec 2009

Grant of $1 million awarded to develop new treatments for dyskinesia

The Michael J. Fox Foundation for Parkinson's Research has awarded $1 million for a clinical study aiming to make a critical step toward the development of new treatments for dyskinesia, the excessive and uncontrollable movements that are a complication of long-term dopamine replacement therapy in patients with Parkinson's disease.

22 Dec 2009

Jamie Oliver to receive the 2010 TED Prize

Jamie Oliver, celebrity chef and standard-bearer in the fight against obesity and other diet related issues, has been announced as the recipient of the 2010 TED Prize, an award granting recipients $100,000 and something much bigger - an opportunity to realize a wish to change the world.

22 Dec 2009

Complete Response letter related to the BLA for azficel-T offered to Fibrocell Science

Fibrocell Science, Inc. announced today that it has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) related to the Biologics License Application (BLA) for azficel-T, an autologous cell therapy for the treatment of moderate to severe nasolabial fold wrinkles in adults.

22 Dec 2009

FDA extends action date for its review of Cephalon's sNDA for NUVIGIL Tablets

Cephalon, Inc. today announced that the U.S. Food and Drug Administration (FDA) has extended the action date to March 29, 2010, for its review of the supplemental New Drug Application (sNDA) for NUVIGIL® (armodafinil) Tablets [C-IV].

22 Dec 2009